X-Body Secures $3,545,000 New Financing

  • Feed Type
  • Date
    11/8/2011
  • Company Name
    X-Body
  • Mailing Address
    100 Beaver Street Waltham, MA 02453
  • Company Description
    The company’s mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates.
  • Website
    http://www.x-bodybiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,545,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The bulk of the new financing would go toward an internal treatment being developed for macular degeneration.
  • M&A Terms
  • Venture Investor
    Undisclosed